Lepu Healthcare: Announcement on the progress of the repurchase of the company's shares
Lepu Healthcare: Announcement on the conversion of convertible corporate bonds to shares in the first quarter of 2024
Lepu Healthcare: An indicative announcement on voluntary disclosure of the administration of the GLP-1/gcGR/GIP-FC fusion protein MWN101 to complete the first phase II clinical trial
Lepu Healthcare: Announcement on the cancellation of some shareholders' equity pledges
Lepu Healthcare: Announcement on 2024 Convertible Corporate Bond Interest Payments
Lepu Healthcare: Announcement on the “Double Improvement of Quality and Return” Action Plan
Lepu Healthcare: Announcement on shareholders' partial equity pledges
Lepu Healthcare: Announcement on the progress of the repurchase of the company's shares
Lepu Healthcare: Announcement on changing the sponsor representative for continuous supervision
Lepu Healthcare: Announcement on the controlling shareholder\'s partial equity pledge
Lepu Medical: Announcement on Subsidiary Companies Participating in Guangdong Alliance Drug Centralized Procurement and Intended to win the bid
Lepu Healthcare: Announcement on the progress of the repurchase of the company\'s shares
Lepu Healthcare: Announcement on receiving a warning letter from the Beijing Securities Regulatory Bureau
Lepu Medical: An indicative announcement on oseltamivir phosphate suspension receiving NMPA registration approval
Lepu Medical: An indicative announcement on the approval of the NMPA registration approval for coronary mastoid balloon dilatation catheters
Lepu Healthcare: Announcement on the completion of the issuance of non-public technology innovation exchangeable corporate bonds for shareholders holding 5% or more of the shares
Lepu Medical: An indicative announcement on obtaining NMPA registration approval for single-use coronary intravascular shock wave catheters
Lepu Healthcare: 2024-004 Announcement on not revising the “Lepu Transfer 2” conversion price downward
Lepu Healthcare: Announcement of Resolutions of the Sixth Meeting of the Sixth Board of Directors
Lepu Healthcare: Announcement on the conversion of convertible corporate bonds to shares in the fourth quarter of 2023
No Data